Literature DB >> 15008033

Adherence to oral therapy for type 2 diabetes: opportunities for enhancing glycemic control.

David Bartels1.   

Abstract

PURPOSE: Although diet and exercise are important parts of type 2 diabetes treatment, most patients require pharmacological intervention with multiple agents to maintain adequate glycemic control. This article addresses the numerous patient-related, disease-related, and demographic variables affecting medication adherence in this patient population. DATA SOURCES: Extensive review of scientific literature, clinical practice guidelines, and Internet sources.
CONCLUSIONS: Studies have demonstrated that treatments including multiple medications or frequent dosing had a negative impact on adherence. Practitioners have used several approaches in an effort to improve adherence to oral antidiabetic medical therapy, including increased communication between health care providers and patients, implementation of multidisciplinary programs, and use of treatment regimens with easier dosing (i.e., reduced number of drugs or doses taken per day). IMPLICATIONS FOR PRACTICE: Options for type 2 diabetes treatments that combine effective medications into a simpler oral-dosage form may motivate and improve patient adherence. Ultimately, simplifying dosing may lead to better glycemic control, thereby reducing the risks associated with long-term consequences of the disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15008033     DOI: 10.1111/j.1745-7599.2004.tb00366.x

Source DB:  PubMed          Journal:  J Am Acad Nurse Pract        ISSN: 1041-2972


  7 in total

Review 1.  The reality of dietary compliance in the management of phenylketonuria.

Authors:  Anita MacDonald; Hulya Gokmen-Ozel; Margreet van Rijn; Peter Burgard
Journal:  J Inherit Metab Dis       Date:  2010-04-07       Impact factor: 4.982

2.  Efficacy and safety of once-weekly oral trelagliptin switched from once-daily dipeptidyl peptidase-4 inhibitor in patients with type 2 diabetes mellitus: An open-label, phase 3 exploratory study.

Authors:  Nobuya Inagaki; Hiroki Sano; Yoshifumi Seki; Shingo Kuroda; Kohei Kaku
Journal:  J Diabetes Investig       Date:  2017-10-30       Impact factor: 4.232

3.  Role of attitudes and intentions in predicting adherence to oral diabetes medications.

Authors:  Emmanuel K Fai; Cheryl Anderson; Victor Ferreros
Journal:  Endocr Connect       Date:  2017-01-13       Impact factor: 3.335

4.  Medication adherence in patients with type 2 diabetes mellitus treated at primary health clinics in Malaysia.

Authors:  Nur Sufiza Ahmad; Azuana Ramli; Farida Islahudin; Thomas Paraidathathu
Journal:  Patient Prefer Adherence       Date:  2013-06-17       Impact factor: 2.711

Review 5.  The significance of compliance and persistence in the treatment of diabetes, hypertension and dyslipidaemia: a review.

Authors:  J A Cramer; A Benedict; N Muszbek; A Keskinaslan; Z M Khan
Journal:  Int J Clin Pract       Date:  2007-11-05       Impact factor: 2.503

Review 6.  What's next after metformin? focus on sulphonylurea: add-on or combination therapy.

Authors:  Phei C Lim; Chee P Chong
Journal:  Pharm Pract (Granada)       Date:  2015-06-15

7.  Efficacy and safety of alogliptin versus acarbose in Chinese type 2 diabetes patients with high cardiovascular risk or coronary heart disease treated with aspirin and inadequately controlled with metformin monotherapy or drug-naive: A multicentre, randomized, open-label, prospective study (ACADEMIC).

Authors:  Bin Gao; Weiguo Gao; Hailong Wan; Fengmei Xu; Rong Zhou; Xia Zhang; Qiuhe Ji
Journal:  Diabetes Obes Metab       Date:  2022-03-22       Impact factor: 6.408

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.